Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER


[Advanced]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Detjen, K M
Right arrow Articles by Rosewicz, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Detjen, K M
Right arrow Articles by Rosewicz, S
Gut 2001;49:251-262 ( August )

Article

Interferon gamma  inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis K M Detjendagger a, K Farwigdagger a b, M Welzela, B Wiedenmanna, S Rosewicza

a Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Universitätsklinikum Charité, Campus Virchow Klinikum, Humboldt Universität zu Berlin, Augustenburger Platz 1, 13353 Berlin, Germany, b Institut für Pharmazie, Freie Universität Berlin, Berlin, Germany

Correspondence to: Professor S Rosewicz. stefan.rosewicz{at}charite.de

Accepted for publication 29 January 2001

BACKGROUND AND AIMS---The poor prognosis of pancreatic cancer is partly due to resistance to a broad spectrum of apoptotic stimuli. To identify intact proapoptotic pathways of potential clinical relevance, we characterised the effects of interferon gamma  (IFN-gamma ) on growth and survival in human pancreatic cancer cells.
METHODS---IFN-gamma receptor expression and signal transduction were examined by reverse transcriptase-polymerase chain reaction (RT-PCR), immunoprecipitation, western blot analysis, and transactivation assays. Effects on cell growth and survival were evaluated in terms of cell numbers, colony formation, cell cycle analysis, DNA fragmentation, and poly(ADP ribose) polymerase (PARP) cleavage.
RESULTS---All four pancreatic cancer cell lines examined expressed functional IFN-gamma receptors and downstream effectors, including the putative tumour suppressor interferon regulatory factor 1 (IRF-1). IFN-gamma treatment profoundly inhibited anchorage dependent and independent growth of pancreatic cancer cells. Cell cycle analyses revealed subdiploid cells suggesting apoptosis, which was confirmed by demonstration of DNA fragmentation and PARP cleavage. Time and dose dependency of apoptosis induction and growth inhibition correlated closely, identifying apoptosis as the main, if not exclusive, mechanism responsible for growth inhibition. Apoptosis was preceded by upregulation of procaspase-1 and accompanied by proteolytic activation. Furthermore, the caspase inhibitor z-vad-fmk completely prevented IFN-gamma mediated apoptosis.
CONCLUSIONS---These results identify an intact proapoptotic pathway in pancreatic cancer cells and suggest that IRF-1 and/or procaspase-1 may represent potential therapeutic targets to be further explored.


Keywords: interferon gamma ; apoptosis; caspase-1;interferon regulatory factor; pancreatic cancer

dagger These authors contributed equally to this work.

© 2001 by Gut


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
K. Wagner, P. Schulz, A. Scholz, B. Wiedenmann, and A. Menrad
The Targeted Immunocytokine L19-IL2 Efficiently Inhibits the Growth of Orthotopic Pancreatic Cancer
Clin. Cancer Res., August 1, 2008; 14(15): 4951 - 4960.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Yoshimoto, N. Morishima, I. Mizoguchi, M. Shimizu, H. Nagai, S. Oniki, M. Oka, C. Nishigori, and J. Mizuguchi
Antiproliferative Activity of IL-27 on Melanoma
J. Immunol., May 15, 2008; 180(10): 6527 - 6535.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
D. S. Dace, P. W. Chen, H. Alizadeh, and J. Y. Niederkorn
Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner
J. Leukoc. Biol., February 1, 2007; 81(2): 421 - 429.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Wu, X. Xiao, P. Zhao, G. Xue, Y. Zhu, X. Zhu, L. Zheng, Y. Zeng, and W. Huang
Minicircle-IFN{gamma} Induces Antiproliferative and Antitumoral Effects in Human Nasopharyngeal Carcinoma
Clin. Cancer Res., August 1, 2006; 12(15): 4702 - 4713.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Liu, S. A. Caldwell, and S. I. Abrams
Immune Selection and Emergence of Aggressive Tumor Variants as Negative Consequences of Fas-Mediated Cytotoxicity and Altered IFN-{gamma}-Regulated Gene Expression
Cancer Res., May 15, 2005; 65(10): 4376 - 4388.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Liu and S. I. Abrams
Coordinate Regulation of IFN Consensus Sequence-Binding Protein and Caspase-1 in the Sensitization of Human Colon Carcinoma Cells to Fas-Mediated Apoptosis by IFN-{gamma}
J. Immunol., June 15, 2003; 170(12): 6329 - 6337.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. A. Iacobuzio-Donahue, A. Maitra, M. Olsen, A. W. Lowe, N. T. Van Heek, C. Rosty, K. Walter, N. Sato, A. Parker, R. Ashfaq, et al.
Exploration of Global Gene Expression Patterns in Pancreatic Adenocarcinoma Using cDNA Microarrays
Am. J. Pathol., April 1, 2003; 162(4): 1151 - 1162.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 BMJ Publishing Group Ltd & British Society of Gastroenterology